Literature DB >> 19775847

High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity.

Brandon P Verdoorn1, Robert Orenstein, Jon E Rosenblatt, Lynne M Sloan, Cathy D Schleck, William S Harmsen, Lisa M Nyre, Robin Patel.   

Abstract

We assessed the prevalence of tcdC deletion-carrying Clostridium difficile using a stool polymerase chain reaction (PCR) assay that detects previously described 18- and 39-bp deletions (J. Clin. Microbiol. 2008;46:1996). We divided inpatients into 2 groups, those for whom the assay detected a deletion in tcdC and those for whom no deletion was detected. We compared risk factors (antibiotic use, hospitalization, nursing home stay, immunocompromise, age >65 years), complications (pseudomembranous colitis, toxic megacolon, colonic perforation, colectomy, and intensive care unit admission), duration of antibiotic treatment, and 30-day mortality between the groups. Forty-two of 141 patients had deletion-positive C. difficile. Prior nursing home stay and age >65 years were significantly more common in the deletion-positive group. Other risk factors, complications, antibiotic duration, and mortality did not differ significantly. Deletion-carrying C. difficile was commonly present but not associated with more severe disease and not markedly different in terms of risk factor profile. Severity of disease was relatively low, regardless of the presence or absence of a deletion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775847     DOI: 10.1016/j.diagmicrobio.2009.08.015

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  17 in total

1.  Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.

Authors:  Stéphanie Sirard; Louis Valiquette; Louis-Charles Fortier
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

2.  Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

Authors:  T Pilate; J Verhaegen; M Van Ranst; V Saegeman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-08       Impact factor: 3.267

3.  Measuring the impact of Clostridium difficile Infection with the NAP1 strain on severity and mortality.

Authors:  Krishna Rao
Journal:  Clin Infect Dis       Date:  2014-06-30       Impact factor: 9.079

4.  Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens.

Authors:  Ognjen Sekulovic; Mathieu Meessen-Pinard; Louis-Charles Fortier
Journal:  J Bacteriol       Date:  2011-03-25       Impact factor: 3.490

5.  Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients.

Authors:  L M Søes; I Brock; S Persson; J Simonsen; K E Pribil Olsen; M Kemp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-10       Impact factor: 3.267

6.  Clostridium difficile ribotype does not predict severe infection.

Authors:  Seth T Walk; Dejan Micic; Ruchika Jain; Eugene S Lo; Itishree Trivedi; Eugene W Liu; Luay M Almassalha; Sarah A Ewing; Cathrin Ring; Andrzej T Galecki; Mary A M Rogers; Laraine Washer; Duane W Newton; Preeti N Malani; Vincent B Young; David M Aronoff
Journal:  Clin Infect Dis       Date:  2012-09-12       Impact factor: 9.079

7.  Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture.

Authors:  M B F Jensen; K E P Olsen; X C Nielsen; A M Hoegh; R B Dessau; T Atlung; J Engberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-25       Impact factor: 3.267

8.  Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC.

Authors:  Søren Persson; Joan N Jensen; Katharina E P Olsen
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

Review 9.  Clostridium difficile infection.

Authors:  Latisha Heinlen; Jimmy D Ballard
Journal:  Am J Med Sci       Date:  2010-09       Impact factor: 2.378

10.  Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.

Authors:  N Esther Babady; Jeffrey Stiles; Phyllis Ruggiero; Perminder Khosa; David Huang; Susan Shuptar; Mini Kamboj; Timothy E Kiehn
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.